The use of regorafenib in colorectal cancer
Colorectal cancer is the third most common type of cancer in men and the second in women worldwide. The data demonstrate the increase in the annual incidence of colorectal cancer, but still the significant number of patients is detected having late-stage cancer. Regorafenib is an oral multi-kinase i...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Habib O.N.
2019-06-01
|
| Series: | Современная онкология |
| Subjects: | |
| Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/33513/pdf |